Webinar | May 26, 2017

Should Your Next Clinical Trial Use A New Supply Model?

Source: Catalent

Clinical supply models need to provide for an adequate supply of patient kits that allow for variations in patient recruitment levels and clinical site activity. Traditional, or supply-led models, address this challenge by creating large quantities of finished patient kits upfront in order to create a cushion of static inventory to manage uneven demand. However, this cushion comes at a cost including lingering potential for stock-outs at high recruiting or new clinical sites, 30-200% drug waste and weeks or even months of lead time for packaging.

Whether you are currently determining the best clinical supply model for an upcoming study or would like to learn more about new approaches to clinical supply this webinar will help you identify strategies to reduce supply chain risk and improve performance.

Key Learning Objectives

  • Understand the fundamental components, benefits and risks of the three major clinical supply models (traditional, JIT labeling, and demand-led) and how each model manages finished patient kit inventory.
  • Understand the root causes of inefficiency within the traditional supply model and explore potential ways to neutralize or lessen their impact either within the current model or through the adoption of a new approach.
  • Understand and describe how the demand-led model fundamentally differs from the traditional and JIT labeling models.
  • Understand key considerations for determining clinical supply model applicability and fit.